1-3 of 3
Lloyd Klickstein
Close
Sort by
Journal Articles

CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell Disease

Vionnie W. C. Yu, PhD, Yi Liu, PhD, Matthew Curran, Pu Zhang, MD, Jennifer Snead, PhD, Christian Schmedt, Yi Yang, PhD, Victor Guosheng Lin, William R Tschantz, PhD, Lisa Quinn, Carsten Russ, Scott Clarkson, Amy Janiak, Morag Stewart, PhD, Yanick Mulumba, Reynald Lescarbeau, Brad Murray, Jessica Seitzer, Walter Strapps, Hon-Ren Huang, Kevin Sloan, Craig S Mickanin, BS, Lloyd Klickstein, MD, Susan Stevenson
Journal: Blood
Blood (2017) 130 (Supplement 1): 535.
https://doi.org/10.1182/blood.V130.Suppl_1.535.535
Published: 2017
Journal Articles

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Corey Cutler, MD MPH FRCPC, David Miklos, MD PhD, Stephanie J. Lee, MD MPH, Sook-Bin Woo, DMD, Nathaniel Treister, DMD, Don Bienfang, MD, Lloyd Klickstein, MD PhD, Jesse Levin, BA, Katherine H. Miller, BA, Carol Reynolds, PhD, Mildred Pasek, RN, Vincent Ho, MD, Jerome Ritz, MD PhD, Joseph H. Antin, MD, Robert Soiffer, MD, Edwin Alyea, MD
Journal: Blood
Blood (2004) 104 (11): 2251.
https://doi.org/10.1182/blood.V104.11.2251.2251
Published: 2004
Journal Articles

Intracellular Storage and Regulated Plasma Membrane Expression of Human Complement Receptor Type 1 in Rat Basophil Leukemia Cell Transfectants

Carolina Jost, Lloyd Klickstein, Erica Wetzler, Anoopa Kumar, Melvin Berger
Journal: Blood
Blood (1998) 92 (1): 300–309.
https://doi.org/10.1182/blood.V92.1.300.413k29_300_309
Published: 1998